Skip to Main Content

Paper Details

Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions.
Sci Rep
10
2018
3D microtumors, GBM, GBM Patient, GBM microtumors, GBM xenoline cells, Glioblastoma multiforme, PDX, Patient, WP1066, cediranib, crizotinib, human, microtumors, patient, patient-derived xenografts, primary malignant brain cancer, selumetinib, tumor, tumors, xenoline, xenolines
Author NameAffiliation
Joshua C AndersonThe University of Alabama at Birmingham
Joshua C AndersonThe University of Alabama at Birmingham
Catherine P LangfordThe University of Alabama at Birmingham
Catherine P LangfordThe University of Alabama at Birmingham
George Yancey GillespieThe University of Alabama at Birmingham
George Yancey GillespieThe University of Alabama at Birmingham
Christopher D WilleyThe University of Alabama at Birmingham
Christopher D WilleyThe University of Alabama at Birmingham
Christopher D WilleyThe University of Alabama at Birmingham
Christopher D WilleyThe University of Alabama at Birmingham
  • 1 - 10

Datasets

Release 1.2